{"name":"Ouro Medicines","slug":"ouro-medicines","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi1wFBVV95cUxPeTdlM0w0Y1pHaExlYXhQeDhhYXVKR0tuR0xpTTZ0TlpOZEZ6TWZTWUdSQUFxY2g3eUxxTVBwdFlpZjRqc2tTdFk2SDJ3dkxsTEJrQzE4LVEyRTBGV0ZUUFl1cUpQVFA0NUZuZ1drZVRTWnk5TWc3UXp5RVFFczhvSC0yVkpySnNUdFRZcGhOaWRFcUJvZkJNa1ZndUFYMmp0c0tOdWlKQmtCSlJqRE9aR2tRRDBTMTBtanBXVHBBamQ0c1c0UlZUNEpodDVlREl6ZWZHU0Q1QQ?oc=5","date":"2026-04-08","type":"deal","source":"MSN","summary":"Gilead to buy Ouro Medicines for $2.2 billion. Why the deal is key to future stock gains. - MSN","headline":"Gilead to buy Ouro Medicines for $2.2 billion. Why the deal is key to future stock gains.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxNQ2hDWnkybkVwbVFDbUhQMzU3YW9WSmpCdkMwN3VPeDNVOHQwTVZDVm1OcTBBN3JYdXBLeE93RFgyenJPa1JFM1pONlgzV2RpeTNnOFYwS25wbGRyWVp5VEh5Uk04RUphUWtYVmJ1OVBZUEh5Wm9HaFZoakstUlZHNlphSzh2SW9URjdMSEMzWUpyLURvZFlfWFltTzczcVRRODJ6TlctakFkeE0?oc=5","date":"2026-03-24","type":"deal","source":"Fierce Biotech","summary":"Gilead's $2.2B Ouro buyout delivers autoimmune T-cell engager, new purpose for Galapagos - Fierce Biotech","headline":"Gilead's $2.2B Ouro buyout delivers autoimmune T-cell engager, new purpose for Galapagos","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxQY2RFbW9zbjAycFlHN1MyeUxyNXhTUFN1ZkVvdXlSLVlvclc1azZ2bWZZVHpDUGpVTTdta245Z2pIY3VhUFlFT1AwM3A5dk5maDhQdlcyNENZUktOdFI1dUVLSXdKOVRkcU56bmtBc0JQVmJWREpQS3g5cUlGZWluaXlTRHN3Q3R2em1Z?oc=5","date":"2026-03-24","type":"deal","source":"Barron's","summary":"Gilead to Buy Ouro Medicines for $2.2 Billion. Why the Deal Is Key to Future Stock Gains. - Barron's","headline":"Gilead to Buy Ouro Medicines for $2.2 Billion. Why the Deal Is Key to Future Stock Gains. - Barron's","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxQQ0FPa3VrQTNwMk9fWjExcm5SQXhxZ0tWSXpjcG5aSVNHcGc3UDhCVW1TQjVZNWw2eG9paW1VQmdDMGFQR3YxVkFYbGdQeG5HdVM5dkd4UVF6Z2NUTk9NaXluZ1JlQ2llTFlLcGIzNy1xX3FwMkRkX0E2ZjRqYWJ0ZUhNQlNmRDFIMVFGeEFfY2Noc2V6dy1qM2pndVVjZ3JtYWlsTm5wQzc0dDg?oc=5","date":"2026-03-24","type":"deal","source":"Pharmaceutical Executive","summary":"Gilead Sciences Enters $2.1 Billion Definitive Agreement to Acquire Ouro Medicines - Pharmaceutical Executive","headline":"Gilead Sciences Enters $2.1 Billion Definitive Agreement to Acquire Ouro Medicines","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTFBiOTdycWNsbmh2ZVlFdlAtMzRhNjRtM19Za0ROVWdPcUF0RlhZcW5pcGZXYUdhYVhmTXU2X1VfMmlsQnR1SlBZUnE4bHNxOFB5d3Fz?oc=5","date":"2026-03-24","type":"deal","source":"FirstWord Pharma","summary":"Gilead's $2.2B deal to buy Ouro gives Galapagos a second chance - FirstWord Pharma","headline":"Gilead's $2.2B deal to buy Ouro gives Galapagos a second chance","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxQUklPSkVkZnNyR2E3SjZEN25abXhBQjFLTi0waXExaHNUd3dIc1pSekRkNS1VVFRST3RhT2lIS3d0TGpTbldScDBQdXhJUXRJMlVBNHhlSktvQTlXdlFhdk40WHBIYTFNTFRqSEFjVjVBMzhac1NrTmE1LUZqT0JjNHJmR0RKcTdTMy03dkhHVmM0YktuOGNYTmlxZDNIRENzc0E?oc=5","date":"2026-03-24","type":"deal","source":"Yahoo Finance","summary":"Gilead acquires first TCE asset with $2.2bn Ouro Medicines buyout - Yahoo Finance","headline":"Gilead acquires first TCE asset with $2.2bn Ouro Medicines buyout","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4gFBVV95cUxPOTlGUC1LTXFUTEdRNGhxc01obVc0YUxIU0h4aTBDd0Z3ZTNnMGU2ZnZRQUdVLXl5UEhJWEl3OEc3OU5lR1JPWWtZYVlJYjZjNjJ6WW1MMkh1UGh3UnFmYTB4UDZjbnB0bjNScm9mSFVFbmY0QUNvR2dxaGZiN19kOW5nSnBwOTRfNHFrb3JocVFXUnkyUnpRZ2tLaEdmclBqY014NWw2VHQwOGwybFI2XzhqUldMVDJsTE5zYzFlWHlzcVNyRVNwTEdkNXlkNlBSbHFLYXcxZVJQQmlVVHRvOXlB?oc=5","date":"2026-03-24","type":"deal","source":"European Pharmaceutical Review","summary":"Gilead acquires potential first-in-class T cell engager in $2bn deal with Ouro Medicines - European Pharmaceutical Review","headline":"Gilead acquires potential first-in-class T cell engager in $2bn deal with Ouro Medicines","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxNbTQwU094TEV4YzNUN3BKeHJ3TlZlTkR5VDNOanFIVjUxV2dBRmZWOGRPV1FHWHZ1WjhkUlFzSUp5YWNmQ2NuemVESm9IZU1lS0xqcXAxQ1pWUXJrVm9LNmdWTlZpcjFTcjJFUXpwY0RrWUZiUTViLTh2b0MyXzVsOUFyNmVqQjQ5UkRnbVpoSWdyRC1NcXc?oc=5","date":"2026-03-24","type":"deal","source":"The Pharma Letter","summary":"Gilead to acquire TCE developer Ouro Medicines - The Pharma Letter","headline":"Gilead to acquire TCE developer Ouro Medicines","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxOMmluNWRCc2Q3YzFaRXQ0VXVHTVc3WmtIYTRoWDdtaVlSRGZCRHl5TmJrTUo4Q09MX1AxdDYxRGhmLXlYQVFHVy11cUh5VFZFWDlkQVhWaXdkazFjZmFhWjNBc3BveHprUC1PVFUxb1hLNHdiRUc2TTFSLUlLTllvZzVORWt6cjlzbzdlOW0tMkVjOUZnUlNR?oc=5","date":"2026-03-24","type":"pipeline","source":"BioSpace","summary":"Gilead Drops $2.1B for Ouro, Hopes To Split Cost with Galapagos - BioSpace","headline":"Gilead Drops $2.1B for Ouro, Hopes To Split Cost with Galapagos","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxNWDBIMGFUUEhtNGRVd2E1UXB0OVJ2UTNnQmRMbnFnV21GWE1TRmJrSFNoalZfaDVqTEVlLVQ3Mkd5T2x3d0k3cXhrTGo0bTJQMmc5aWx2OHhpc29ERWtGb3hJcHRYa2pWWGVVQTc1SXRvellGUGdpSGV2bVlyQTYtN2xGWVlrMVN2dGdHNk9kOG13blo0bUV2Nzk1Sk1GRktvUlZkTFVpYVVoeFVHa1lwZEtsOElBdnRTQzBUaWEtZw?oc=5","date":"2026-03-24","type":"trial","source":"Endpoints News","summary":"Gilead bets $1.68B upfront on Ouro Medicines’ autoimmune program, with Galapagos expected to pitch in - Endpoints News","headline":"Gilead bets $1.68B upfront on Ouro Medicines’ autoimmune program, with Galapagos expected to pitch in","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAJBVV95cUxOTlhseXNvUzFGd0JMLW1mN2RpeFZET240WDlraWx2am0yb09vdGtvN3FISlNaTlNYVlZPRU1EdUE0YkhMMGJsQjNaZmYwOF9yeW9Ea1N4UE1mVDNicWlIU2YwMHBLLWVhOGxkMHFhaHBsNk9BVEo3TGlud2JNbzEtRHRXQi1WSlJadi1hUW9welIyeWdxY3llMGh1Smw4VWtEV255Z0F5WlJ3dGxXMF94RFNCblI3RTNfLXpfQjRzdnZGTUcxTjhNbE5kSERNV0dqYWJ4YWtLazlvQzZJNVZVRFphVmEwYXNKZzVKWTViWk5IWXhCUWVOSVVSVzBOR09w?oc=5","date":"2026-03-23","type":"deal","source":"businesswire.com","summary":"Gilead Sciences to Acquire Ouro Medicines to Advance First in Class T Cell Engager Program for Autoimmune Diseases - businesswire.com","headline":"Gilead Sciences to Acquire Ouro Medicines to Advance First in Class T Cell Engager Program for Autoimmune Diseases","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxQNXNfWWwtRHpGdUNMYnBKQ2JraHRiQkp1NldsVW9NMlI2NE50TmEycHlzcmpLZC02YzI1WkpkX01XcWRsaXlYNHQ3eEpROXg4QXp1Z2FmOFlmV3d1eWxMZmV4bVoxSFpZQ1Z0UDJEeGJUWV84LVhkcHNpTG9CNXhpWHcyaW5pME1yUFpiMFg2eFBhdHdzU3J5NS1QZmF2Y19vODN0WUpEODRpYVJXRmZMNzdZY3Jhdw?oc=5","date":"2026-03-23","type":"deal","source":"Bloomberg.com","summary":"Gilead to Buy Ouro Medicines for Its Autoimmune Drugs - Bloomberg.com","headline":"Gilead to Buy Ouro Medicines for Its Autoimmune Drugs","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}